More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$2.35B
EPS
2.09
P/E ratio
12.7
Price to sales
1.11
Dividend yield
--
Beta
0.610144
Previous close
$28.84
Today's open
$29.78
Day's range
$28.59 - $29.78
52 week range
$16.90 - $30.05
show more
CEO
James D. Swift
Employees
2150
Headquarters
Sunrise, FL
Exchange
New York Stock Exchange
Shares outstanding
81253271
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Pediatrix Medical Group, Inc. (MD) Q3 2026 Earnings Call Transcript
Pediatrix Medical Group, Inc. ( MD ) Q3 2026 Earnings Call October 29, 2026 9:00 AM EDT Company Participants David Haddock - Executive Vice President, General Counsel & Secretary Mark Ordan - CEO & Executive Chairman Kasandra Rossi - Executive VP, Treasurer & CFO Conference Call Participants Matthew Mardula - William Blair & Company L.L.C., Research Division Albert Rice - UBS Investment Bank, Research Division Jack Slevin - Jefferies LLC, Research Division Benjamin Mayo - Leerink Partners LLC, Research Division Pito Chickering - Deutsche Bank AG, Research Division Presentation Operator Hello, and thank you for standing by.
Seeking Alpha • 4 hours ago

Pediatrix Medical Group Reports Third Quarter Results
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group Reports Third Quarter Results.
Business Wire • 14 hours ago

Pediatrix Medical Group (MD) Beats Q3 Earnings and Revenue Estimates
Pediatrix Medical Group (MD) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.63 per share. This compares to earnings of $0.67 per share a year ago.
Zacks Investment Research • 11 hours ago

Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026
FORT LAUDERDALE, Fla.--(BUSINESS WIRE)---- $MD--Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026.
Business Wire • Oct 20, 2026

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Oct 9, 2026

HB Wealth Expands Into Texas With Experienced Three-Advisor Team
ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD, CFP®, and Lauren Podnos-Garner, CFP®, have joined the firm. Together, the three advisors establish the firm's presence in Austin, Texas, with Rachel and Lauren based in Austin and Steven dividing his time between Austin and Cocoa Beach, Florida. The trio previously operated Wealth Care LLC, an inde.
Business Wire • Oct 1, 2026

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Zacks Investment Research • Sep 22, 2026

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Sep 15, 2026

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Zacks Investment Research • Sep 3, 2026

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Sep 1, 2026

¹ Disclosures

Open an M1 investment account to buy and sell Pediatrix Medical Group Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.